Cite
HARVARD Citation
Kerckhove, N. et al. (2018). Efficacy and safety of a T‐type calcium channel blocker in patients with neuropathic pain: A proof‐of‐concept, randomized, double‐blind and controlled trial. European journal of pain. pp. 1321-1330. [Online].